Dublin, Jan. 18, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/5rzpcl/the_global) has announced the addition of the "The Global Glucose Monitoring Market" report to their offering.
Diabetes is a leading cause of death and disability in the worldwide. It increases the risk for heart disease, end-stage renal disease, blindness, amputation, andcomplications of pregnancy and is ranked as the sixth leading cause of death. Disease prevalence is driving sales of monitoring equipment. The glucose monitoring device and diabetes management market is focused on utilizing advancements recently introduced to provide easier-to-use products and more accurate glucose monitoring.
The Global Glucose Monitoring Market provides market estimates and forecasts for this important test category. As part of its coverage, the report breaks out the revenues earned by the glucose monitoring industry into appropriate segments so that businesses can assess the right market opportunity for the area they compete in.
There are many issues facing this industry. Some issues are helping to propel the market; while other issues are retarding growth forward. Issues and trends driving the market for glucose monitoring devices and diabetes management include: New innovations, Reimbursement challenges, Recalls, Aging of the population, Increasing life expectancy, Healthcare spending trends, Advances in sensors, Health insurance portability, Cost cutting, Healthcare efficiency, Capacity challenges, Growing acceptance of mobile technologies and other factors. These are discussed at length in the report, as are their role in market growth.
Although there are many participants in the market, a handful of companies continue to make a significant impact on the glucose monitoring devices and diabetes management market.
A select few are discussed here, including:
- Abbott Laboratories
- AgaMatrix Arkray, Inc
- Bayer Diabetes Bionime Corporation
- DexCom, Inc.
- Echo Therapeutics
- Entra Health Systems LLC
- Fora Care Inc
- Genesis Health Technologies
- GlySure Limited
- Insulet
- Johnson & Johnson
- Medtronic
- Nipro Diagnostics, Inc
- Nova Diabetes Care, Inc.
- Oak Tree International Holdings, Inc
- Prodigy Diabetes Care, LLC
- Roche U.S. Diagnostics, Inc.
Key Topics Covered:
- Executive Summary
- Introduction
- Traditional Glucose Monitoring Devices And Diabetes Management Market
- Continuous Glucose Monitoring And Sensor Market
- Issues And Trends
- Global Glucose Monitoring Devices And Diabetes Management Market And Competitor Analysis
- Market Analysis By Region
- Corporate Profiles
For more information visit http://www.researchandmarkets.com/research/5rzpcl/the_global
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Glucose Testing, Diabetes Devices


Apple Intelligence Cleared for China as Alibaba and Baidu AI Power iPhone Features
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth
Richemont Q1 Sales Beat Forecast as Cartier Demand Drives Strong Growth
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast
Volkswagen Launches €28,000 ID. Cross EV as Europe’s Electric Vehicle Demand Accelerates
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business
SEB Q2 Profit Rises on Strong Lending, Record Fee Income, Announces New Share Buyback
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States
SK Hynix Stock Soars as AI Memory Demand Outlook Fuels Chip Rally
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside
Alibaba Stock Jumps as China Approves Apple Intelligence Powered by Qwen AI 



